BRITTANY RIZOS: Open Payments
NPI 1497397160 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 17 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $166 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $161 |
| GlaxoSmithKline, LLC. | 5 | $141 |
| ZOLL Respicardia, Inc. | 2 | $117 |
| Lilly USA, LLC | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| HARMONY BIOSCIENCES LLC | 1 | $24 |
Products named: NUCALA, remede System, ZEPBOUND, OFEV, FASENRA, WAKIX.
Industry payments across PA — which companies pay providers there.
